Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
asthma
Pharma
In battle with GSK's Nucala, AZ's Fasenra wins FDA nod for EGPA
The FDA has signed off on AstraZeneca's Fasenra to treat eosinophilic granulomatosis with polyangiitis, a rare, immune-mediated vascular disorder.
Kevin Dunleavy
Sep 18, 2024 11:46am
FTC launches investigation into Teva's inhaler patents: report
Jul 2, 2024 10:02am
Teva notches loss in inhaler patent case against Amneal
Jun 12, 2024 9:35am
GSK plays defense on call to pull popular children's asthma med
May 3, 2024 10:19am
Regeneron, Sanofi tweak Dupixent message for latest asthma ads
Apr 29, 2024 7:00am
FTC blasts Teva for 'improper' inhaler patents
Mar 25, 2024 10:04am
